Commentary: The stem cell bridge: Forging a path above cold storage
Heart transplantation remains the gold standard of treatment for patients with end-stage heart failure, with a median survival of 13 years.1 However, owing to the scarce and stagnant supply of donor organs in the United States over the past 3 decades, patients continue to experience significant mortality on the waiting list. Although one of the significant limitations is supply, the other is inherent to the current standard of donor organ preservation—cold static storage—which poses temporal and geographic challenges to facilitating safe, equitable organ allocation.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Jason J. Han, Amit Iyengar, Pavan Atluri Tags: Commentary Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Heart Failure | Heart Transplant | Stem Cell Therapy | Stem Cells | Transplants | USA Health